Company Contents
Quick Facts & Snapshot
Summary
The Biobank Consumables market is entering a mature yet expansionary growth phase, with US$ 2.38 Billion in 2025 and steady progression toward US$ 3.93 Billion by 2032 at 7.40% CAGR. Demand is driven by biobanking standardization, sample integrity, and automation. Leading Biobank Consumables market companies leverage innovation, regulatory compliance, and global service networks to consolidate share.
Source: Secondary Information and ReportMines Research Team - 2026
Ranking Methodology
The ranking of Biobank Consumables market companies combines quantitative and qualitative dimensions into a composite score. Core quantitative inputs include estimated 2025 Biobank Consumables revenue, three-year segment CAGR, and share of global biobanking installations supported. Qualitative metrics cover portfolio breadth across tubes, cryovials, plates, reagents, and storage accessories; strength of QA/QA systems and regulatory compliance; geographic reach and distributor depth; and the ability to support long-term supply and service agreements with large biobanks, CROs, and hospital networks. Technology differentiation, such as traceability-enabled consumables, barcoding and RFID integration, low-temperature durability, and automation readiness, is weighted heavily. Strategic factors—including alliances with LIMS vendors, OEM relationships with freezer and automation providers, and track record in large project wins—are assessed through public disclosures and expert interviews. Each company receives a normalized score, and final rankings reflect both scale and strategic positioning.
Top 10 Companies in Biobank Consumables
Source: Secondary Information and ReportMines Research Team - 2026
Detailed Company Profiles
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific is a global life sciences leader providing comprehensive biobank consumables, cold-chain solutions, and integrated sample-management technologies.
Merck KGaA (MilliporeSigma)
Merck KGaA, via MilliporeSigma, delivers high-quality biobanking plastics and reagents aligned with GMP and regulatory-intensive applications.
Corning Incorporated
Corning offers a broad portfolio of cryogenic vials, storage bottles, and plates optimized for long-term biobanking and sample integrity.
Sarstedt AG & Co. KG
Sarstedt specializes in blood collection and storage systems, providing integrated consumables for clinical and population biobanks.
Greiner Bio-One International GmbH
Greiner Bio-One provides vacuette collection systems and biobanking plastics, emphasizing reliability and sustainability in sample storage.
Brooks Life Sciences (Azenta Life Sciences)
Azenta Life Sciences combines automated sample storage platforms with specialized consumables for high-density, high-throughput biobanks.
BioLife Solutions, Inc.
BioLife Solutions focuses on biopreservation media and associated consumables supporting cell, gene therapy, and tissue biobanks.
Ziath Ltd.
Ziath delivers 2D-barcoded tubes and tracking consumables that enhance sample traceability and data integrity for modern biobanks.
Starlab International GmbH
Starlab supplies lab plastics and consumables that increasingly serve mid-sized clinical and research biobanks.
CryoSave Technologies
CryoSave Technologies targets cord blood, stem cell, and tissue biobanks with specialized cryogenic consumables and kits.
SWOT Leaders
Thermo Fisher Scientific Inc.
SWOT Snapshot
Comprehensive consumables portfolio, strong automation partnerships, and unmatched global distribution and technical support capabilities.
Complex product catalog can complicate procurement decisions and create internal portfolio overlaps in certain biobanking segments.
Expansion of population-scale genomic and longitudinal cohort biobanks in emerging markets and secondary cities worldwide.
Aggressive price competition from regional manufacturers and potential supply-chain volatility for specialized polymers and resins.
Merck KGaA (MilliporeSigma)
SWOT Snapshot
Strong reputation in regulated environments, high product quality, and integrated reagent-plus-consumables offerings.
Premium pricing constrains penetration in cost-sensitive public sector and low-income country biobanks.
Growth of hospital-based precision medicine biobanks and expanding GMP-compliant storage requirements.
Local competitors scaling good-enough consumables and evolving sustainability regulations impacting plastics choices.
Corning Incorporated
SWOT Snapshot
Deep expertise in glass and polymer sciences, robust global brand, and wide installed base of lab plastics.
Exposure to general laboratory spending cycles can create volatility in biobank-focused investments.
Rising demand for low-extractable, high-purity storage consumables in biomarker and multi-omics biobanks.
Substitution by alternative materials and intensifying competition from specialized biobank-only consumable providers.
Biobank Consumables Market Regional Competitive Landscape
North America remains the largest Biobank Consumables market, driven by NIH-funded repositories, major oncology biobanks, and cell therapy centers. Thermo Fisher Scientific Inc., Corning Incorporated, and Azenta Life Sciences dominate high-end solutions, while BioLife Solutions, Inc. capitalizes on preservation media demand supporting advanced therapy and regenerative medicine biobanks.
Europe shows strong institutional and national cohort programs, underpinning stable demand for high-quality consumables. Merck KGaA (MilliporeSigma), Sarstedt AG & Co. KG, and Greiner Bio-One International GmbH anchor the region, supported by stringent quality expectations and well-funded public-health biobanks in Germany, the Nordics, and the United Kingdom.
Asia Pacific is the fastest-growing Biobank Consumables market region, propelled by expanding population genomics initiatives in China, Japan, South Korea, and Australia. Corning Incorporated and Thermo Fisher Scientific Inc. leverage local manufacturing and partnerships, while regional manufacturers intensify price competition in tubes, plates, and racks segments for hospital biobanks.
Latin America and the Middle East are emerging growth frontiers, with rising investments in cord blood, oncology, and infectious-disease biobanks. CryoSave Technologies and BioLife Solutions, Inc. gain traction with niche cryogenic and preservation consumables, while global players pursue distributor-led models to address fragmented demand and procurement complexity.
In Central and Eastern Europe, mid-sized hospital and private diagnostic biobanks are expanding, creating opportunities for cost-effective yet high-quality consumables. Starlab International GmbH and Ziath Ltd. increasingly serve these customers with affordable plastics and traceability-focused solutions aligned with evolving data and sample integrity regulations.
Biobank Consumables Market Emerging Challengers & Disruptive Start-Ups
Emerging Challengers & Disruptive Start-Ups
Develops ultra-durable, RFID-enabled cryovials and racks that integrate natively with major LIMS platforms for real-time sample traceability.
Offers bio-based, recyclable biobank tubes and plates aimed at reducing plastic waste while maintaining cryogenic performance standards.
Provides advanced nano-coating technologies for vials and plates, minimizing leachables and adsorption losses in sensitive biomarker samples.
Designs modular, high-density rack and box systems optimized for robotic freezers, enabling capacity gains in constrained biobank facilities.
Combines low-cost barcoded consumables with cloud-based tracking software tailored for emerging-market hospital and public-health biobanks.
Biobank Consumables Market Future Outlook & Key Success Factors (2026-2032)
From 2025 to 2031, cumulative investments in metro expansions and station safety upgrades are projected to surpass significant amounts. The total market will scale from US$ 2.27 Billionin 2025 to US$ 3.38 Billion by 2031, reflecting a 6.90% CAGR. Winning Biobank Consumables market companies will share several attributes. First, they will embed native IoT sensors, enabling predictive maintenance contracts that can double recurring revenue within five years. Second, modular design philosophies—interchangeable panels, plug-and-play controllers—will shorten installation windows and appeal to cost-sensitive public operators.
Localization strategies will also define competitive edges. Suppliers that establish regional assembly plants to meet content rules in India, Brazil, or the U.S. are likely to capture bonus points in tenders. Finally, sustainability credentials will move from optional to mandatory. Recyclable composite panels, energy-efficient brushless motors, and life-cycle carbon disclosures will become bid differentiators. In short, the coming decade rewards Biobank Consumablesmarket companies that marry digital intelligence with manufacturing agility and regulatory foresight.
Frequently Asked Questions
Find answers to common questions about this company report.